Thus, there is a need for new treatment alternatives for patients with MDD. One such option is magnetic seizure therapy (MST).In ECT, shunting of electrical current by the scalp and skull and conduction of electrical current through the cerebrospinal fluid results in a nonfocal and large total electrical charge delivered to the brain [6]. Such diffuse activation may be the mechanism through which neurocognitive adverse effects (e.g., memory impairment) occurs. By contrast, the magnetic fields used in MST are unimpeded and thus focal, requiring a lower total electrical charge to elicit an effective seizure [6]. This may account for the reports of absent or minimal effects of MST on neurocognitive function [7].